Roux-Lombard P, Modoux C, Vischer T, Grassi J, Dayer J M
Division of Immunology and Allergy (Hans Wilsdorf Laboratory), University Hospital, Geneva, Switzerland.
J Rheumatol. 1992 Apr;19(4):517-23.
Measurement of interleukin 1 (IL-1) in synovial fluids (SF) yielded variable results and implied the presence of an inhibitory activity. As peripheral blood monocytes produce an IL-1 receptor antagonist (IL-1ra), we investigated whether SF mononuclear cells (SFMC) also secreted such inhibitory activity. MC isolated from inflammatory SF produced, in addition to variable levels of IL-1, a specific IL-1 inhibitor of approximately 23 kDa which blocked both IL-1 biological activity and binding to its receptor. Western blot, using a polyclonal antibody to rhIL-1ra, indicated that SFMC secreted material that shared immunological crossreactivity with the cloned IL-1ra. IL-1 inhibitory activity was also detected in SF but not formally demonstrated to be related to IL-1ra. In conclusion, SFMC could produce IL-1ra and an imbalance between IL-1 and its specific antagonist may be relevant to the severity of joint destruction.
对滑液(SF)中白细胞介素1(IL-1)的检测结果不一,提示存在抑制活性。由于外周血单核细胞可产生IL-1受体拮抗剂(IL-1ra),我们研究了滑液单核细胞(SFMC)是否也分泌这种抑制活性物质。从炎性滑液中分离出的单核细胞,除了可产生不同水平的IL-1外,还产生一种约23 kDa的特异性IL-1抑制剂,该抑制剂可阻断IL-1的生物学活性及其与受体的结合。用抗重组人IL-1ra多克隆抗体进行的蛋白质印迹分析表明,SFMC分泌的物质与克隆的IL-1ra具有免疫交叉反应性。在滑液中也检测到了IL-1抑制活性,但尚未正式证明其与IL-1ra有关。总之,SFMC可产生IL-1ra,IL-1与其特异性拮抗剂之间的失衡可能与关节破坏的严重程度有关。